Shares of China's CanSino Biologics rise as much as 15% on W...

股票&市场分析

浏览 333万内容 5429

SEA Hedge 参与了话题 · 2021/12/15 14:44

Shares of China's CanSino Biologics rise as much as 15% on Wednesday afternoon.
Cansino and Aerogen are teaming up to develop and market an inhaled version of CanSino's recombinant COVID-19 shot Convidecia, which is already approved in China as a one-and-done injectable.

康希诺生物日内走高，一度涨超15%，此前宣布与Aerogen合作开发全球首款吸入式新冠疫苗。

$康希诺生物 (06185.HK)$ $康希诺 (688185.SH)$

免责声明：社区由Moomoo Technologies Inc.提供，仅用于教育目的。更多信息